Teligent Inc. recently announced that the U.S. Food and Drug Administration (FDA) has granted approvals for its abbreviated new drug applications (ANDAs) for Triamcinolone Acetonide Lotion USP, 0.1 percent and Triamcinolone Acetonide Lotion USP, 0.025 percent. Read More »
William D. Waddill, who is the SVP and CFO for Calithera Biosciences, has been elected to the Protagonist Therapeutics Inc. Board of Directors, Protagonist announced last week. Read More »
The CVS Health Research Institute recently released the results of a new study that has determined that medication reconciliation programs have decreased hospital readmissions. Read More »
Stent releases drug to reduce scar tissue in coronary arteries after angioplasty. Read More »
Genticel has announced that it has approached Eumedix, a renowned European corporate finance specialist, for strategic advising. Read More »
Provides grant to American Academy of Pediatrics to improve providers' counseling on tobacco and secondhand smoke exposure. Read More »
CVS Pharmacy MinuteClinic locations across the country recently introduced health services and immunizations related to travel to assist patients in their preparation for the travel season. Read More »
Seasoned executive joins Amarin senior management team. Read More »
BELKYRA received a positive opinion by the Swedish Medical Products Agency. Read More »
FDA also grants Orphan Drug Designation for the therapy. Read More »
PDL BioPharma recently announced that its has agreed to a $75 million initial equity investment in Noden Pharma DAC, a privately held company based in Ireland, and an affiliate. Read More »
Opens mobile pharmacy to provide pharmacy services to Elkview residents. Read More »
Cigna and Hill Physicians Medical Group have announced that the two companies have agreed to enter a care program partnership that will put an emphasis on the improvement of patient health while decreasing the cost. Read More »
SPIRE-HR and SPIRE-FH lipid-lowering studies meet primary endpoints. Read More »
Copay increases could affect TRICARE beneficiaries' access to prescriptions. Read More »
Store scheduled to open in the mixed use complex in December. Read More »
Ampio Pharmaceuticals Inc. recently announced the results from its PIVOT clinical trials to access the efficacy and safety of Ampion intra-articular injection among patients who have pain from osteoarthritis (OA) in their knees. Read More »
The agreements allow AstraZeneca to focus on its main therapy areas. Read More »
Patent submitted to the FDA Orange Book for approval on June 28. Read More »
Two software programs to integrate and automate medical reviews and payment authorizations. Read More »
Alerts Sign-up
